Iran Starts Human Test of Home-Made Coronavirus Vaccine
TEHRAN (FNA)- Iran’s Health Minister Saeed Namaki said that the country has a century of experience and know-how in the production of vaccines, and announced that the human trial of the COVID-19 vaccine has started with the first injection on Tuesday of the domestic vaccine.
"We have been producing vaccines in the country for a hundred years. Pasteur Institute of Iran was set up in 1920 and Razi Vaccine and Serum Research Institute was founded in 1924," Namaki said on the sidelines of the unveiling ceremony of the vaccine and the first phase of the clinical trial of Iranian-made COVID-19 vaccine on 56 volunteers.
"We were the first producer of vaccines in Asia and we have sent vaccines to many countries in the world," he added.
Iran’s Health Minister Saeed Namaki
"Due to our record in vaccine production, we are trying to offer new vaccines with the help of the Science and Technology Vice-Presidency, knowledge-based companies, the Pasteur Institute of Iran, the Razi Vaccine and Serum Research Institute and the private sector," the minister noted.
"We have developed various platforms for coronavirus, including the vaccine, the first human phase of which was performed today," Namaki said, and added, "Another platform is also underway at Razi Institute, and its animal tests are underway and will soon receive a human testing license."
"We hope that we will soon see the start of the second human trial phase of this national vaccine and then the third phase to be followed by its mass production," he continued.
The Headquarters for Executing the Order of Imam (Khomeini) announced the start of the first phase of the clinical trial of Iranian-made COVID-19 vaccine on 56 volunteers in Tehran on Tuesday.
The COVID-19 vaccine produced by EIKO has been licensed by the Iranian Ministry of Health and Medical Education.
In relevant remarks on Monday, Head of the Coronavirus Research Team of Iran’s Headquarters for Executing the Order of Imam, Hassan Jalili, said that the coronavirus vaccine developed by his country will have a 90% efficiency and is strong enough to resist against the virus mutations.
“If everything goes well and once the human trial phases are accomplished, mass-production of the coronavirus vaccine will take about four to five months before it is supplied to the public,” Jalili said in an interview with the Persian-language Jam-e Jam newspaper on Monday.
“Domestically-produced vaccines have common platforms with vaccines from other countries that have entered the human trial phase. Similar statistical data and numerical platforms tested in other countries show that the vaccine is up to 90% efficient in bringing about immunity to the coronavirus,” he added.
Meantime, Jalili said that Iran will wait until the end of human trial phase to precisely assess the effectiveness of the home-made vaccine.
“I believe the vaccine we have developed can be resistant to the virus mutation. The statistical information we have emphasizes this point,” he added.